Detalhe da pesquisa
1.
Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients.
Haematologica
; 100(3): e90-2, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25425692